Testing & Diagnostic Services
Timing is critical for prenatal, neonatal, and maternal testing. National organizations such as the American Congress of Obstetricians and Gynecologists (ACOG) recommend making the option of first trimester prenatal screening available to all pregnant women, regardless of maternal age. And both ACOG and the American College of Medical Genetics (ACMG) recommend complete genetic disorder testing in the first few days of life.
Our products and services allow the earliest possible identification of pregnancy disorders. We alone use the biomarker free beta hCG to assist in the detection of Down syndrome and trisomy 18 and 13 aneuploidies. Free beta hCG has been validated by clinical studies examining over 260,000 patients in total. This patented technology provides the highest detection rates available in the first trimester of pregnancy, giving families more time to prepare.
Efficiency during first trimester office visits helps both families and physicians. Using our proprietary software, physicians can offer an instant risk assessment for aneuploidies on the spot to their patients. Routine recommended maternal carrier testing for cystic fibrosis can be combined with the prenatal screen, and paternal cystic fibrosis carrier testing can be performed at home and sent in to our laboratory.
We provide the most comprehensive panel of genetic tests for newborns available. Our new automated platforms can run multiple tests simultaneously on a few drops of blood. And we never stop developing new products to protect mothers and babies—like additional assays for chromosomal abnormalities as well as assay kits to assess the risk of preterm birth, preeclampsia, and intrauterine growth retardation. Our goal is to protect your patient’s pregnancy, baby, and family.